Nu-Med Plus (NUMD) 10-K 23 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 10, 2015	Jun. 30, 2014
Document and Entity Information:
Entity Registrant Name	Nu-Med Plus, Inc.
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Entity Central Index Key	1543637
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		34,660,645
Entity Public Float			$13,660,645
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

NUMED_PLUS_INC_Balance_Sheets

NU-MED PLUS, INC. Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash	$56,271	$13,229
Prepaid expenses, current	115,851	17,995
Total current assets	172,122	31,224
Long-term assets
Property and equipment, net	37,379	43,242
Prepaid expenses, long-term	3,561	21,556
Total long-term assets	40,940	64,798
Total assets	213,062	96,022
Current liabilities
Accounts payable	0	116
Accrued Expense	36,728	20,862
Convertible Promissory Note, Due on demand, net	230,100	199,384
Total current liabilities	266,828	220,362
Stockholders' equity (deficit)
Preferred stock; $0.001 par value per share; 10,000,000 authorized; no shares issued and outstanding, respectively.	0	0
Common stock; $0.001 par value per share; 90,000,000 authorized; 34,281,347 and 29,972,346 shares issued and outstanding, as of December 31, 2014 and December 31, 2013 respectively.	34,281	29,972
Additional paid-in capital	1,703,360	404,063
Stock subscription payable	0	40,300
Accumulated deficit	-1,791,407	-598,675
Total stockholders' equity (deficit)	-53,766	-124,340
Total liabilities and stockholders' equity (deficit)	$213,062	$96,022

NuMed_Plus_Inc_Balance_Sheet_P

Nu-Med Plus, Inc. Balance Sheet (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position
Preferred stock authorized	10,000,000	10,000,000
Preferred stock par value	$0.00	$0.00
Preferred stock issued	0	0
Preferred stock outstanding	0	0
Common stock authorized	90,000,000	90,000,000
Common stock par value	$0.00	$0.00
Common stock issued	34,281,347	29,972,346
Common stock outstanding	34,281,347	29,972,346

NUMED_PLUS_INC_Statements_of_O

NU-MED PLUS, INC. Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement
Revenue	$0	$0
Operating expenses
General and administrative expense	60,166	20,538
Payroll expense	56,887	49,571
Rent expense	16,656	16,656
Professional and consulting Fees	1,005,448	143,676
Depreciation and amortization expense	6,964	3,195
Total operating expenses	1,146,121	233,636
Operating Loss	-1,146,121	-233,636
Other income and expense
Interest income	13	1
Interest expense	-46,624	-98,655
Total other income and expense	-46,611	-98,654
Income tax expense	0	0
Net loss	($1,192,732)	($332,290)
Basic and diluted loss per share	($0.04)	($0.01)
Weighted average common shares outstanding - basic and diluted	32,787,397	27,819,829

NuMed_Plus_Inc_Statements_of_S

Nu-Med Plus, Inc. Statements of Stockholders' Equity (Deficit) (USD $)	Preferred Stock	Common stock	Additional Paid-In Capital	Stock Subscription Receivable/Payable	Accumulated Deficit	Total
Stockholders' Equity, beginning balance at Dec. 31, 2012	$0	$26,804	$193,497	$0	($266,385)	($46,084)
Balance common shares, beginning balance at Dec. 31, 2012	0	26,804,012	0	0	0	26,804,012
Balance preferred shares, beginning balance at Dec. 31, 2012	0	0	0	0	0	0
Services contributed by officers	0	0	3,184	0	0	3,184
Common Stock issued for loan conversion, shares	0	168,334	0	0	0	168,334
Common Stock issued for loan conversion, value	0	168	50,332	0	0	50,500
Common Stock issued to contractors, shares	0	3,000,000	0	0	0	3,000,000
Common Stock issued to contractors, value	0	3,000	42,000	0	0	45,000
Beneficial conversion feature	0	0	115,050	0	0	115,050
Net loss	0	0	0	0	-332,290	-332,290
Stockholders' Equity, ending balance at Dec. 31, 2013	0	29,972	404,063	40,300	-598,675	-124,340
Stock Subscription Payable at Dec. 31, 2013	0	0	0	40,300	0	40,300
Balance common shares, ending balance at Dec. 31, 2013	0	29,972,346	0	0	0	29,972,346
Balance preferred shares, ending balance at Dec. 31, 2013	0	0	0	0	0	0
Services contributed by officers	0	0	10,905	0	0	10,905
Common Stock issued for cash shares	0	809,001	0	0	0	809,001
Common Stock issued for cash, value	0	809	241,891	-40,300	0	202,400
Common Stock issued to contractors, shares	0	3,500,000	0	0	0	3,500,000
Common Stock issued to contractors, value	0	3,500	1,046,500	0	0	1,050,000
Net loss	0	0	0	0	-1,192,732	-1,192,732
Stockholders' Equity, ending balance at Dec. 31, 2014	0	34,281	1,703,360	0	-1,791,407	-53,766
Stock Subscription Payable at Dec. 31, 2014						$0
Balance common shares, ending balance at Dec. 31, 2014	0	34,281,347	0	0	0	34,281,347
Balance preferred shares, ending balance at Dec. 31, 2014	0	0	0	0	0	0

NUMED_PLUS_INC_Statements_of_C

NU-MED PLUS, INC. Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	($1,192,732)	($332,290)
Depreciation	6,964	3,195
Amortization of stock for services	970,139	72,602
Services rendered for subscription receivable	0	0
Services contributed by officers	10,905	3,184
Amortization of the Beneficial Conversion Feature	30,716	84,334
Decrease in prepaid expenses	0	25,000
Increase in accounts payable	-116	-10,470
Increase in accrued expense	15,867	13,962
Net cash used in operating activities	-158,257	-140,483
Cash flows from investing activities:
Purchases of property and equipment	-1,101	-28,919
Net cash used in investing activities	-1,101	-28,919
Cash flows from financing activities
Proceeds from the sale of common stock	202,400	40,300
Proceeds from loans payable	0	141,600
Net cash provided by financing activities	202,400	181,900
Net increase(decrease) in cash	43,042	12,498
Cash at beginning of period	13,229	731
Cash at end of period	56,271	13,229
Supplemental schedule of cash flow information
Cash paid for interest	0	0
Cash paid for income taxes	$0	$0

Organization_and_Description_o

Organization and Description of Business	12 Months Ended
	Dec. 31, 2014
Notes
Organization and Description of Business	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS
	Nu-Med Plus, Inc. is an emerging growth early stage medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. The Company's immediate focus is on a Nitric Oxide powder formulation that is 99% pure-with one year shelf life, a "desktop" generator device with controls plus safety monitors built in that delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a compact mobile rechargeable device to deliver inhaled Nitric Oxide gas. The Company is incorporated in Utah.
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	a. Accounting Method
	The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments which are necessary for a fair statement of the results for interim periods have been included.
	b. Revenue Recognition
	The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.
	c. Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
	d. Cash and Cash Equivalents
	The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.
	e. Fixed Assets
	Fixed assets are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the fixed assets are depreciated are five to seven years.
	f. Earnings per Share
	The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement.
		For the year ended December 31, 2014	For the year ended December 31, 2013
	Net loss (numerator)	(1,192,732)	(332,290)
	Shares (denominator)	32,787,397	27,819,829
	Net loss per share amount	(0.04)	(0.01)
	Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. During the year there were no outstanding common stock equivalents. Furthermore, due to the net loss for the year, common stock equivalents would not be included in the calculation of the net loss per common share, as their inclusion would be anti-dilutive.
	g. Income Taxes
	Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	h. Equity Instruments Issued for Non-Cash Items
	In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.
	NOTE 3 - GOING CONCERN
	The Company anticipates that the funds on hand as of December 31, 2014, will not be sufficient and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $275,000 for 2015. The Company is currently funded through April 1, 2015.The Company has begun the process of arranging for additional necessary funding and currently retains consultants for that purpose. Management will adjust any salaries and expenditures based on the need for successful continuous operations. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Fixed_Assets

Fixed Assets	12 Months Ended
	Dec. 31, 2014
Notes
Fixed Assets
	NOTE 4 - FIXED ASSETS
	Fixed assets and related accumulated depreciation consisted of the following at December 31, 2014, and December 31, 2013:
		31-Dec-14	31-Dec-13
	Computer and office equipment	$         49,373	$         48,273
	Accumulated depreciation	-11,994	-5,031
	Total Fixed Assets	$       37,379	$       43,242
	Depreciation expense for the year ended December 31, 2014 and 2013, was $6,964 and $3,195, respectively.

Preferred_and_Common_Stock

Preferred and Common Stock	12 Months Ended
	Dec. 31, 2014
Notes
Preferred and Common Stock
	NOTE 5 - PREFERRED STOCK
	On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share.  No preferred shares are issued or outstanding at December 31, 2014.
	NOTE 6 - COMMON STOCK
	In November and December of 2013, the Company received $40,300 for a Stock Subscription Payable.  In January and February of 2014, the Company received $38,400 for a Stock Subscription Payable. The Stock Subscription Payable was relieved in February 2014 by the issuance of 262,333 shares of common stock at a value of $ 0.30 per share.
	On January 7, 2014, the Company issued 1,800,000 common shares valued at $0.30per share for a total value of $540,000 to a consultant, as compensation, for current and future services to be provided from the date of issuance through January 7, 2015.
	In April of 2014, the Company received $6,500 for a Stock Subscription Payable.  The Stock Subscription Payable was relieved in May 2014 by the issuance of 21,666 shares of common stock at a value of $0.30 per share.
	In April of 2014, the Company entered into a stock subscription agreement with two investors for them to purchase up to $165,000 of common stock at a price of $0.30 per share.  By September 2014, the Company received $157,500 for that Stock Subscription Payable.  The Stock Subscription at June 30, 2014 was relieved on September 16, 2014, by the issuance of 525,002 shares of common stock at a value of $0.30 per share.
	On May 23, 2014, the Company issued 350,000 common shares valued at $0.30 per share for a total value of $105,000 to a consultant, as compensation, for future services to be provided from June 1, 2014 through June 1, 2015.
	On May 24, 2014, the Company issued 200,000 common shares valued at $0.30 per share for a total value of $60,000 to a consultant, as compensation, for future services to be provided from June 1, 2014 through June 1, 2015.
	On July 1, 2014, the Company issued 150,000 common shares valued at $0.30 per share for a total value of $45,000 to a consultant, as compensation, for current and future services to be provided from June 1, 2014 through June 1, 2015.
	On October 1, 2014, the Company issued 200,000 common shares valued at $0.30 per share for a total value of $60,000 to a consultant, as compensation, for current and future services to be provided from September 24, 2014, through December 31, 2014.
	On October 1, 2014, the Company issued 800,000 common shares valued at $0.30 per share for a total value of $240,000 to a consultant, as compensation, for future services to be provided from October 1, 2014 through December 31, 2014.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Notes
Commitments and Contingencies
	NOTE 7 - COMMITMENTS AND CONTINGENCIES
	Operating Lease Obligations
	The Company leases office space for which it incurred lease payments, on a month to month basis, beginning in February of 2012 for $1,000 per month.  The Company also had a one year lease on lab space beginning April 1, 2012 and ending March 31, 2013, with a monthly lease payment of $388.  Pursuant to the lease agreement, at the end of one year, the term is month to month at the same rate of $388 per month.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Notes
Related Party Transactions
	NOTE 8 - RELATED PARTY TRANSACTIONS
	Contributed Services
	During the year ended December 31, 2014 and 2013, the Company officers contributed services to the Company in the amount of $10,905 and $3,184, respectively. The Company officers received no compensation and have no expectation of compensation for these services, either now or in the future, and waive their rights to any such compensation.

Loan_Payable

Loan Payable	12 Months Ended
	Dec. 31, 2014
Notes
Loan Payable
	NOTE 9 - LOAN PAYABLE
	The Company received, during the year ended December 31, 2013, proceeds from a loan in the amount of $91,600. The Lender has agreed to loan the Company up to $10,000 per month effective September 2012, for up to one year  This loan was memorialized in writing on September 30, 2013. The loan is considered to be a demand note, with a maturity 30 days from the receipt of demand and the holder may not make demand for payment until six month from the date thereof. On June 30, 2014, the Company accrued additional interest on this note, at a rate of 8.0% in the amount of $5,161 for six months. The total loan balance and accrued interest is $130,100 and $13,842 respectively.  The note contains a conversion option.  The conversion price is one share for each $0.01 of principal and accrued but unpaid interest of the note subject to a beneficial ownership limitation. That limitation prevents the holder from owning more than 4.9% of the number of shares of the common stock outstanding after conversion. If the holder's ownership has not previously been reduced to less than 4.9% of the number of shares outstanding, then the limitation shall be 9.9%.
	On September 4, 2013 the Company entered into an agreement with a shareholder wherein shareholder would provide financing to the Company for two months at $25,000 per month.  The note is due six months from the date it is presented and surrendered to the Company and bears an interest rate of 8.0% per annum.  In September and October 2013, the Company received two $25,000 loans for a total of $50,000, and on October 28, 2013, the outstanding balance of $50,000 along with accrued interest of $500 was converted into common stock at a value of $0.30 per share.
	On November 14, 2012, the Company issued a $100,000 convertible promissory note to a consultant as compensation for services provided and to be provided during the period April, 1, 2012, through March 31, 2013.  This note is due on demand, bears annual interest at 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion. On September 27, 2013, the Company amended the note to include the conversion price which is one share for each $0.01 of principle and accrued but unpaid interest of the note.  Of the original $100,000, $75,000 had been expensed as part of the professional/consulting fees on the statement of operations during the year ended December 31, 2012, and the remaining $25,000 was expensed ratably using the straight-line method over the last three months in the service period.  On December 31, 2014, the Company has accrued additional interest on this note in the amount of $5,500 for the year ended December 31, 2014. As of December 31, 2014, the company accrued interest on this note in the total amount of $15,129.
	The Company has evaluated these convertible under the provisions of ASC Topic 815 and has concluded that neither of the convertible contains an embedded derivative requiring bifurcation from the host contract. Therefore, we have accounted for the conversion features of these instruments in accordance with ASC Topic 470. Accordingly, we have recognized the value of beneficial conversion features in these instruments as the difference between the conversion price and the fair value of the Company’s common stock on the date of the transaction.  As a result the Company has recognized debt discounts resulting from these beneficial conversion features amounting to $50,000 and $65,050, respectively, for the November 14, 2012 and September 27, 2013 notes.  The value of these discounts is to be accreted to the loans over the remaining contractual lives of the loans.  Accretion recognized as additional interest expense during the periods ended December 31, 2014 and December 31, 2013 was $30,716 and $84,334, respectively. The ending value of the debt discount as of December 31, 2014 and December 31, 2013 was $0 and $30,716, respectively.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Notes
Income Taxes
	NOTE 10 – INCOME TAXES
	The provision (benefit) for income taxes for the years ended December 31, 2014, and 2013, consists of the following:
			2014			2013
	Federal:
	Current	$	0	$	0
	Deferred		0		0
	State:
	Current		0		0
	Deferred		0		0
	Total	$	0	$	0
	The income tax provision differs from the amount of income tax determined by applying the U.S. federal and applicable state income tax rates to pretax income from continuing operations for the years ended December 31, 2014, and 2013, due to the following:
			2014		2013
	Book Income	$	-465,200	$	-129,600
	Depreciation		-1,100		-200
	Shares issued for services		378,400		-25,500
	Contributed services		4,300		1,200
	Beneficial Conversion Feature Amortization		12,000		32,900
	Valuation allowance		71,600		121,200
	Total	$	0	$	0
	Net deferred tax liabilities consist of the following components as of December 31, 2014, and 2013:
				2014		2013
	Deferred tax assets:
		NOL Carryover	$	298,700	$	227,000
	Deferred tax liabilities
		Depreciation		-4,800		-3,700
	Valuation allowance			(293,900)		(223,300)
	Net deferred tax asset		$	0	$	0
	Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal income tax reporting purposes are subject to annual limitations.  If a change in ownership occurs, then net operating loss carryforwards may be limited as to use in future years.  At December 31, 2014, the Company had net operating loss carryforward of approximately $766,000 that may be offset against future taxable income from the year 2015 through 2031. The availability of some of the net operating loss will extend into 2034 if not previously utilized. During 2014, the Company evaluated its deferred tax assets and concluded that none of the asset is currently realizable and that a full valuation allowance should be recorded.  The valuation allowance increased by $70,600 and leaves the Company with a net deferred tax asset of $0 as of December 31, 2014.
	Included in the balance at December 31, 2014, are no tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.  Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Notes
Subsequent Events
	NOTE 11 - SUBSEQUENT EVENTS
	The Company has evaluated subsequent events in accordance with ASC Topic 855 and has determined that there are no reportable subsequent events.

Organization_and_Description_o1

Organization and Description of Business (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Accounting Method
	a. Accounting Method
	The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments which are necessary for a fair statement of the results for interim periods have been included.
Revenue Recognition
	b. Revenue Recognition
	The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.
Estimates
	c. Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Cash and Cash Equivalents
	d. Cash and Cash Equivalents
	The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.
Fixed Assets
	e. Fixed Assets
	Fixed assets are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the fixed assets are depreciated are five to seven years.
Earnings Per Share
	f. Earnings per Share
	The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement.
		For the year ended December 31, 2014	For the year ended December 31, 2013
	Net loss (numerator)	(1,192,732)	(332,290)
	Shares (denominator)	32,787,397	27,819,829
	Net loss per share amount	(0.04)	(0.01)
	Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. During the year there were no outstanding common stock equivalents. Furthermore, due to the net loss for the year, common stock equivalents would not be included in the calculation of the net loss per common share, as their inclusion would be anti-dilutive.
Income Taxes
	g. Income Taxes
	Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Equity Instruments Issued For Non-cash Items
	h. Equity Instruments Issued for Non-Cash Items
	In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.
Going Concern
	NOTE 3 - GOING CONCERN
	The Company anticipates that the funds on hand as of December 31, 2014, will not be sufficient and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $275,000 for 2015. The Company is currently funded through April 1, 2015.The Company has begun the process of arranging for additional necessary funding and currently retains consultants for that purpose. Management will adjust any salaries and expenditures based on the need for successful continuous operations. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Organization_and_Description_o2

Organization and Description of Business (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted		For the year ended December 31, 2014	For the year ended December 31, 2013
	Net loss (numerator)	(1,192,732)	(332,290)
	Shares (denominator)	32,787,397	27,819,829
	Net loss per share amount	(0.04)	(0.01)

Fixed_Assets_Tables

Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Property, Plant and Equipment
		31-Dec-14	31-Dec-13
	Computer and office equipment	$         49,373	$         48,273
	Accumulated depreciation	-11,994	-5,031
	Total Fixed Assets	$       37,379	$       43,242

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Components of Income Tax Expense (Benefit)
			2014			2013
	Federal:
	Current	$	0	$	0
	Deferred		0		0
	State:
	Current		0		0
	Deferred		0		0
	Total	$	0	$	0
Schedule of Effective Income Tax Rate Reconciliation
			2014		2013
	Book Income	$	-465,200	$	-129,600
	Depreciation		-1,100		-200
	Shares issued for services		378,400		-25,500
	Contributed services		4,300		1,200
	Beneficial Conversion Feature Amortization		12,000		32,900
	Valuation allowance		71,600		121,200
	Total	$	0	$	0
Schedule of Deferred Tax Assets and Liabilities
				2014		2013
	Deferred tax assets:
		NOL Carryover	$	298,700	$	227,000
	Deferred tax liabilities
		Depreciation		-4,800		-3,700
	Valuation allowance			(293,900)		(223,300)
	Net deferred tax asset		$	0	$	0

Items_Details

Items (Details)	12 Months Ended
	Dec. 31, 2014
Details
Cash Flow, Supplemental Disclosures	Supplemental schedule of non-cash financing activities During the twelve months ended Dec 31, 2014, the Company issued 3,500,000 shares of common stock for services provided by consultants.

Organization_and_Description_o3

Organization and Description of Business (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Net loss	($1,192,732)	($332,290)
Weighted average common shares outstanding - basic and diluted	32,787,397	27,819,829
Basic and diluted loss per share	($0.04)	($0.01)
Planned expenditures	$275,000

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Property, Plant and Equipment, Gross	$49,373	$48,273
Accumulated Depreciation	-11,994	-5,031
Property and equipment, net	37,379	43,242
Depreciation	$6,964	$3,195

Preferred_and_Common_Stock_Det

Preferred and Common Stock (Details) (USD $)	0 Months Ended	1 Months Ended			2 Months Ended	12 Months Ended
	Jan. 07, 2014	31-May-14	Apr. 30, 2014	Jan. 31, 2014	Feb. 28, 2014	Dec. 31, 2014	Dec. 31, 2013	Oct. 01, 2014	Sep. 16, 2014	Jul. 01, 2014	24-May-14	23-May-14	Apr. 15, 2014
Details
Preferred stock authorized						10,000,000	10,000,000
Preferred stock par value						$0.00	$0.00
Stock subscription payable			$157,500			$0	$40,300						$6,500
Proceeds from the sale of common stock					38,400	202,400	40,300
shares issued for stock subscription									525,002
Stock Subscription Price Per Share						$0.30
Common Stock issued to contractors, shares	1,800,000		165,000	1,800,000		3,500,000	3,000,000
Price per share of shares issued for services						$0.30
total value of shares issued for compensation						540,000
Stock subscription shares		21,666
Sale of Stock, Price Per Share						$0.30
share based compensation shares								200,000		150,000	200,000	350,000
share based compensation value								60,000		45,000	60,000	105,000
ShareBasedCompensationSharesFutureServices								800,000
Share Based Compensation Value Future Services								$240,000

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Details
monthly office lease payment	$1,000
monthly lab lease payment	$388

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Services contributed by officers	$10,905	$3,184

Loan_Payable_Details

Loan Payable (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Details
Additional Loan Proceeds	$91,600
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current	The Lender has agreed to loan the Company up to $10,000 per month effective September 2012, for up to one year
Accounts Payable, Interest-bearing, Interest Rate	8.00%
additional loan accrued interest	5,161
Convertible Notes Payable	130,100
convertible note payable accrued interest	13,842
Debt Instrument, Convertible, Terms of Conversion Feature	The conversion price is one share for each $0.01 of principal and accrued but unpaid interest of the note subject to a beneficial ownership limitation. That limitation prevents the holder from owning more than 4.9% of the number of shares of the common stock outstanding after conversion. If the holder's ownership has not previously been reduced to less than 4.9% of the number of shares outstanding, then the limitation shall be 9.9%.
Shareholder Loan Amount Per Month	25,000
Related Party Transaction, Amounts of Transaction	50,000
Debt Conversion, Original Debt, Amount	50,000
Debt Conversion Accrued Interest	500
Debt Instrument, Convertible, Conversion Price	0.3
Convertible Promissory Note, Due on demand, net	230,100	199,384	100,000
Decrease in prepaid expenses	0	25,000	75,000
Additional Convertible Promissory Note Accrued Interest	5,500
Debt Instrument, Convertible, Interest Expense	15,129
Debt Instrument, Convertible, Beneficial Conversion Feature		65,050	50,000
Amortization of the Beneficial Conversion Feature	30,716	84,334
Amortization of Debt Discount (Premium)	$0	$30,716

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Current Federal Tax Expense (Benefit)	$0
Deferred Federal Income Tax Expense (Benefit)	0
Current State and Local Tax Expense (Benefit)	0
Deferred State and Local Income Tax Expense (Benefit)	0
Current Income Tax Expense (Benefit)	0
Income Tax Expense (Benefit), Continuing Operations	-465,200	-129,600
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount	-1,100	-200
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount	378,400	-25,500
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	4,300	1,200
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount	12,000	32,900
Valuation Allowance, Deferred Tax Asset, Change in Amount	71,600	121,200
Total	0	0
Deferred Tax Assets, Operating Loss Carryforwards	298,700	227,000
Deferred Tax Liabilities, Other	-4,800	-3,700
Tax Credit Carryforward, Valuation Allowance	-293,900	-223,300
Deferred Tax Assets, Net	0	0
Deferred Tax Assets, Tax Credit Carryforwards	766,000
Valuation Allowances and Reserves, Period Increase (Decrease)	$70,600